Vaccine adjuvants : immunological and clinical principles
Author(s)
Bibliographic Information
Vaccine adjuvants : immunological and clinical principles
(Infectious disease)
Humana Press, c2006
- : alk. paper
Available at 4 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
A cutting-edge review of the major research areas of adjuvant discovery, design, development, and use. The authors lay down a rational basis for vaccine adjuvant function and analyze a number of significantly distinct adjuvant-active molecules to illuminate the principles of their function and use. The focus is on specific receptor-ligand interactions, including the molecular features needed for a compound to possess adjuvant activity. The critical interface zone between the innate and adaptive immune systems is also analyzed to show how adjuvants exert their effects on T- and B-cell activation. Additional chapters address the possibility of tailoring adjuvants to yield optimally safe and effective responses.
Table of Contents
Microbial Pathogenesis and the Discovery of Toll-Like Receptor Function
Bruce Beutler
Dendritic Cells: Targets for Immune Modulation by Microbes and Immunologists
Bali Pulendran, Anshu Agrawal, Stephanie Dillon, and Sudhanshu Agrawal
Achieving Transcriptional Specificity in NF-kB-Dependent Inflammatory Gene Expression
Gioacchino Natoli
Adjuvants and the Initiation of T-Cell Responses
Matthew F. Mescher, Julie M. Curtsinger, and Marc Jenkins
Mechanism for Recognition of CpG DNA
Kiyoshi Takeda, Hiroaki Hemmi, and Shizuo Akira
CpG ODN As a Th1 Immune Enhancer for Prophylactic and Therapeutic Vaccines
Arthur M. Krieg and Heather L. Davis
Modified Bacterial Toxins
Ed C. Lavelle, Olive Leavy, and Kingston H. G. Mills
Glycosylphosphatidylinositol Anchors As Natural Immunological Adjuvants Derived From Protozoan Parasites
Ricardo T. Gazzinelli, Catherine Ropert, Igor C. Almeida, Joao S. Silva, and Marco A. Campos
The Immunomodulatory Glycan LNFPIII/Lewis X Functions As a Potent Adjuvant for Protein Antigens
Mitsuhiro Okano, Kazunori Nishizaki, Akram Da'dara, Paul Thomas, Michele Carter, and Donald A. Harn, Jr.
Immune and Antiviral Effects of the Synthetic Immunomodulator Murabutide: Molecular Basis and Clinical Potential
George M. Bahr
Effect of QS-21 on Innate and Adaptive Immune Responses
Charlotte Read Kensil, Gui Liu, Christine Anderson, and James Storey
Monophosphoryl Lipid A and Synthetic Lipid A Mimetics As TLR4-Based Adjuvants and Immunomodulators
Jory Baldridge, Kent Myers, David Johnson, David Persing, Christopher Cluff, and Robert Hershberg
Microparticles and DNA Vaccines
Kimberly Denis-Mize, Manmohan Singh, Derek T. O'Hagan, Jeffrey B. Ulmer, and John J. Donnelly
Index
by "Nielsen BookData"